HOME >> MEDICINE >> NEWS
Lexapro receives FDA approval for the treatment of generalized anxiety disorder

NEW YORK, December 18 - Forest Laboratories, Inc. (NYSE:FRX) announced today that the U.S. Food and Drug Administration (FDA) has approved Lexapro (escitalopram oxalate), a selective serotonin reuptake inhibitor (SSRI), for the treatment of generalized anxiety disorder (GAD), a condition that affects approximately four million Americans annually. The new indication is based on three studies, all of which were positive and support the efficacy and safety of Lexapro in the treatment of GAD. GAD is characterized by excessive anxiety and worry that significantly impacts an individual's daily functioning. Lexapro is also indicated for the initial treatment and maintenance of major depressive disorder.

"One of the biggest challenges in treating GAD patients is finding a treatment that is not only effective, but also one that patients will be able to tolerate for the long term," said Philip Ninan, M.D., professor of Psychiatry and Behavioral Sciences and director of the Mood and Anxiety Disorders Program at Emory University School of Medicine. "Lexapro is a first-line treatment option, which has proven to be effective with a favorable side effect profile."

Study Details

All three studies that support the indication approval were randomized, double-blind, eight weeks in duration and placebo-controlled. The studies involved approximately 850 patients, 18 to 80 years of age, diagnosed with GAD. Patients in the Lexapro arm were administered a fixed dose of 10 mg per day for the first four weeks and then flexibly dosed to a maximum of 20 mg per day. The Hamilton Anxiety Scale (HAMA) total score was the primary efficacy variable, and secondary efficacy measures included changes in HAMA psychic anxiety subscale and Clinical Global Impressions (CGI) scores. In each of the three studies, Lexapro 10 to 20 mg per day significantly improved GAD symptoms in patients compared to placebo as measured by change from baseline in HAMA score. By-visit anal
'"/>

Contact: Charles E. Triano
212-224-6714
Forest Laboratories
18-Dec-2003


Page: 1 2

Related medicine news :

1. Starting dose of Lexapro as effective as optimally dosed Zoloft in the treatment of depression
2. UIC professor receives international humanitarian award
3. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
4. Epidemiologist Trichopoulos receives $5.8 million Department of Defense Innovator Award
5. GlaxoSmithKline receives unanimous favorable recommendation by FDA Advisory Committee for Boostrix
6. NYU Child Study Center receives grant from the American Red Cross September 11 recovery program
7. Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program
8. American Academy of Neurology program receives Grassroots Award
9. Orqis receives FDA approval to expand clinical trial of Cancion CRS therapy to 40 centers
10. Mayo Clinic Cancer Center receives SPORE grant for brain cancer research from NCI
11. Pfizers antifungal medicine VFEND receives FDA approval

Post Your Comments:
(Date:6/30/2015)... Church, VA (PRWEB) , ... June 30, 2015 ... ... 29th Annual Conference will be held October 28-31, 2015 at Disney’s Coronado Springs ... of continuing nursing education and networking. Each year, this premiere event for psychiatric-mental ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... This Fourth ... aligned with the Peacock Alley story including hard work, tenacity, perseverance, commitment to quality, ... was born. , Born of Mary Ella Gabler's simple love of quilts, Peacock ...
(Date:6/29/2015)... ... June 30, 2015 , ... Sublime Beauty NATURALS® introduces its new USDA Certified ... ideal for natural skincare and even culinary uses, was especially designed for Oil Pulling. ... desire, and Oil Pulling can accomplish this. Oil Pulling is an Ayurvedic practice that ...
(Date:6/29/2015)... Grove, Utah (PRWEB) , ... June 30, 2015 , ... ... pleased to announce its involvement in a much-needed autism support center, planned at Utah ... from the Regents formal approval for the center and the building in which it ...
(Date:6/29/2015)... ... June 29, 2015 , ... Healthpointe, one of Southern ... A. Mitamura, MD., PhD into their world-class multidisciplinary team of physicians and specialists. ... Beach , Irwindale and La Tijera-Los Angeles. , Orthopedic surgeons of Healthpointe, ...
Breaking Medicine News(10 mins):Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 2Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 3Health News:Luxury Linen Purveyor Peacock Alley Celebrates the Fourth of July 2Health News:New Product: Transform Wellness and Oral Health With This Ancient Ayurvedic Secret and Organic Product from Sublime Beauty NATURALS® 2Health News:doTERRA Partners With Utah Valley University on Autism Support Center 2Health News:doTERRA Partners With Utah Valley University on Autism Support Center 3Health News:Renowned Orthopedic and Spine Surgeon Joins Healthpointe in Long Beach 2Health News:Renowned Orthopedic and Spine Surgeon Joins Healthpointe in Long Beach 3
(Date:6/30/2015)... Legal-Bay LLC, the Lawsuit Settlement Funding Company, announced today ... (MDL) over the Zimmer NexGen Knee implant lawsuits has ... There are currently more than a thousand cases against ... judge in Illinois . The judge ... October of this year. Zimmer Inc. previously issued voluntary ...
(Date:6/30/2015)... 2015 PharmaVentures is pleased to ... Technologies Oy (CMT) on its divestment of certain assets ... CMTs world leading capabilities in cellular imaging and analysis. ... series of successful global deals in the life science ... Fintan Walton , CEO, PharmaVentures, commented: "PharmaVentures is delighted ...
(Date:6/29/2015)... Mordor Intelligence presents their Global Pharmaceutical Packaging Market ... Metal) - ByType of Packaging (Ampules, Blister Packs, Bottles, Canisters, ... By Geographical Region ( North America , ... Latin America , Middle East ... Industry Value Chain Analysis, Porter,s 5 Force Analysis, Drivers, Restraints, ...
Breaking Medicine Technology:Legal-Bay Lawsuit Settlement Funding Reports Zimmer NexGen Knee Bellwether Trial to Begin October 13th, 2015 2Legal-Bay Lawsuit Settlement Funding Reports Zimmer NexGen Knee Bellwether Trial to Begin October 13th, 2015 3PharmaVentures Completes M&A Deal for Technology in the Stem Cell & Regenerative Medicine Sector 2Global Pharmaceutical Packaging Market - North America and Europe Expected to Lead Followed by the Asia Pacific Market 2Global Pharmaceutical Packaging Market - North America and Europe Expected to Lead Followed by the Asia Pacific Market 3
Cached News: